Red cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management
Yazdanbakhsh K, Ware RE, Noizat-Pirenne F: Red cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012; 120:528-537
Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death
Chadebech P, Habibi A, Nzouakou R, et al.: Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion 2009; 49:1785-1792
A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
Birgens H, Frederiksen H, Hasselbalch HC, et al.: A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol 2013; 163:393-399
An attempt to induce transient immunosuppression pre-erythrocytapheresis in a girl with sickle cell disease, a history of severe delayed hemolytic transfusion reactions and need for hip prosthesis
Cattoni A, Cazzaniga G, Perseghin P, et al.: An attempt to induce transient immunosuppression pre-erythrocytapheresis in a girl with sickle cell disease, a history of severe delayed hemolytic transfusion reactions and need for hip prosthesis. Hematol Rep 2013; 28:5
Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia
Bachmeyer C, Maury J, Parrot A, et al.: Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. Am J Hematol 2010; 85:91-92
Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient
Delmonte L, Cantini M, Olivieri O, et al.: Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient. Transfusion 2013; 53:688-689
Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti Rh linked to partial Rh phenotype
Silvy M, Tournamille C, Babinet J, et al.: Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti Rh linked to partial Rh phenotype. Haematologica 2014; 99:e115-117.
